Form 10-Q ZIMMER BIOMET HOLDINGS, For: Sep 30

Go back to Form 10-Q ZIMMER BIOMET HOLDINGS, For: Sep 30

Zimmer Biomet (ZBH) PT Lowered to $175 at Truist Securities

November 4, 2021 6:09 PM EDT

Truist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $175.00 (from $188.00) while maintaining a Buy rating.

The analyst commented, "The third quarter was another noisy event for Zimmer Biomet headlined by COVID, staffing, and VBP headwinds that impacted... More